Forskolin-resistant Y1 adrenal cell mutants are deficient in adenylyl cyclase type 4

Mol Cell Endocrinol. 2004 Feb 12;214(1-2):155-65. doi: 10.1016/j.mce.2003.10.066.

Abstract

Four mutant clones independently derived from the Y1 mouse adrenocortical tumor cell line have adenylyl cyclase (AC) activities that are resistant to forskolin, a direct activator of AC. In this study the AC isoform composition of the forskolin-resistant mutants was examined in order to explore the underlying basis for the resistance to forskolin. As determined by Western blot and RT-PCR analysis, the four forskolin-resistant mutants all were deficient in AC-4; the levels of other AC isoforms (AC-1, AC-3 and AC-5/6) were comparable to the levels in parent Y1 cells. Transfection of one of the mutant clones with an AC-4 expression vector increased forskolin-stimulated cAMP signaling, and restored forskolin-induced changes in cell morphology and growth. Taken together, these observations indicate that AC-4 deficiency is a hallmark of the forskolin-resistant phenotype of these mutants and suggest that AC-4 is an important target of forskolin action in the Y1 adrenal cell line.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenylyl Cyclases / analysis
  • Adenylyl Cyclases / deficiency*
  • Adenylyl Cyclases / physiology
  • Adrenal Cortex Neoplasms / genetics
  • Adrenal Cortex Neoplasms / pathology*
  • Animals
  • Cell Division
  • Cell Line, Tumor
  • Cell Size
  • Colforsin / pharmacology*
  • Cyclic AMP / biosynthesis
  • Dose-Response Relationship, Drug
  • Drug Resistance*
  • Mice
  • Mutation
  • Protein Isoforms / analysis
  • RNA, Messenger / analysis

Substances

  • Protein Isoforms
  • RNA, Messenger
  • Colforsin
  • Cyclic AMP
  • Adenylyl Cyclases
  • adenylyl cyclase 4